Press Releases

Myomo Receives Technology License Fee Payment from China Joint Venture Company

Read More >

April 10, 2023

Myomo Makes NYSE American Section 610(b) Public Announcement

Read More >

March 15, 2023

Myomo Reports Fourth Quarter and Full Year 2022 Financial Results

Read More >

March 13, 2023

Myomo to Report Fourth Quarter Financial Results on March 13, 2023

Read More >

March 6, 2023

Myomo To Participate in the 35th Annual Roth Conference 

Read More >

March 6, 2023

MyoPro Approved in Australia by National Disability Insurance Scheme

Read More >

February 6, 2023

Myomo Appoints Yitzchak Jacobovitz to its Board of Directors

Read More >

January 30, 2023

Myomo Announces Closing of $6.5 Million Upsized Public Offering

Read More >

January 17, 2023

Myomo Announces Pricing of $6.5 Million Upsized Public Offering

Read More >

January 12, 2023

Myomo Announces Initiative to Reduce Cash Burn

Read More >

January 10, 2023

Myomo Provides Update on Progress to Obtain Medicare Part B Reimbursement for MyoPro

Read More >

December 7, 2022

Ruling by German Social Court Supports MyoPro Reimbursement by Nation’s Statutory Health Insurance System

Read More >

December 5, 2022